ADMA Biologics Inc (NASDAQ:ADMA)

9.80
Delayed Data
As of 10:52am ET
 +0.2199 / +2.30%
Today’s Change
6.76
Today|||52-Week Range
14.00
-12.27%
Year-to-Date

Today’s Trading

Previous close9.58
Today’s open9.77
Day’s range9.77 - 9.80
Volume701
Average volume (3 months)15,457
Market cap$89.0M
Dividend yield--
Data as of 10:52am ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)-35.23%
Earnings growth (this year)+26.75%
Earnings growth (next 5 years)--
Revenue growth (last year)+174.35%
P/E ratioNM
Price/Sales16.61
Price/Book4.13

Competitors

 Today’s
change
Today’s
% change
TENXTenax Therapeutics I...0.000.00%
CFRXContraFect Corp-0.06-1.38%
ICELCellular Dynamics In...0.000.00%
PTIEPain Therapeutics In...+0.06+3.12%
Data as of 10:48am ET, 02/27/2015

Financials

Next reporting dateMarch 27, 2015
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$3.1M
Annual profit (last year)-$15.5M
Net profit margin-506.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Adam S. Grossman
Chief Financial Officer &
Vice President
Brian Lenz
Corporate headquarters
Ramsey, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account